维普中文期刊产品整合服务

Antiplatelet aggregation activity of some ferrocenylphenylimine compounds

查看全文 作  者:Monisola [1]I.Ikhile;Foluso [2]O.Osunsanmi;Andy [2]R.Opoku;J.Catherine [1]Ngila 高影响力作者 机构地区:[1]Department of Applied Chemistry,University of Johannesburg,Doornfontein Campus;[2]Department of Biochemistry and Microbiology,University of Zululand,private Bag X1001高影响力机构 出  处:《Journal of Chinese Pharmaceutical Sciences》索引2017年第26卷第6期,共5页高影响力期刊 基  金:Global Excellence and Stature(GES),2016,University of Johannesburg 摘  要:Platelet hyper-aggregability triggered death and disability due to cardiovascular diseases is increasing worldwide and becoming a global concern. Therefore, it is necessary to synthesize newer drugs for the management of platelet aggregation. In this study, we investigated the antiplatelet aggregation activity of a novel series of ferrocenylimine compounds(3–10), N-(3-nitro-2-hydroxylbenzylidene)-3-ferrocenylimine(3), N-(3-bromo-2-hydroxylbenzylidene)-3-ferrocenylimine(4), N-(3-bromo-5-chlorosalicylidene)-3-ferrocenylimine(5), N-(ferrocenylformidene)-3-ferrocenylimine(6), N-(3-nitro-2-hydroxylbenzylidene)-4-ferrocenylimine(7), N-(3-bromo-2-hydroxylbenzylidene)-4-ferrocenylimine(8), N-(3-bromo-5-chlorosalicyl)-4-ferrocenylimine(9), N-(ferrocenylformidene)-4-ferrocenylimine(10) on thrombin-and ADP-induced platelet aggregation. The synthesized ferrocenylimine compounds(3–10) were found to exhibit higher antiplatelet aggregation activity than their precursors, which are 3-ferrocenylaniline(compound 1) and 4-ferrocenylaniline(compound 2). Among the derivatives, compounds 5, 6 and 10 possessed excellent platelet aggregation inhibition against the agonists. 关 键 词:FERROCENE IMINE Antiplatelet aggregation THROMBIN PLATELET
相关文献

参考文献(21)

耦合文献(2)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费